New Treatment for Non-Hodgkin Lymphoma Approved

WEDNESDAY, Aug. 8, 2018 — Poteligeo (mogamulizumab) injection has been approved by the U.S. Food and Drug Administration to treat adults with two types of non-Hodgkin lymphoma.
The drug was approved to treat relapsed or refractory mycosis fungoides…
Source: Topamax